CONMED CORPORATION Deferred Income Tax Liabilities, Net
CONMED CORPORATION (CNMD) had Deferred Income Tax Liabilities, Net of $84.58 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-07-29
- 2026-06-30: Deferred Income Tax Liabilities, Net $84.58M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $79.53M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $74.86M.
- 2025-06-30: Deferred Income Tax Liabilities, Net $69.82M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $84.58M 10-Q · filed 2026-07-29 |
| 2025-12-31 | $79.53M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $74.86M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $69.82M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $69.95M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $74.08M 10-K · filed 2026-02-17 |
| 2024-09-30 | $65.82M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $64.94M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $64.00M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $60.90M 10-K · filed 2025-02-18 |
| 2023-09-30 | $66.91M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $66.08M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $65.55M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $66.72M 10-K · filed 2024-02-28 |
| 2022-09-30 | $112.58M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $105.94M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $63.23M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $68.54M 10-K · filed 2023-02-21 |
| 2021-09-30 | $58.94M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $57.62M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $56.59M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $57.88M 10-K · filed 2022-02-22 |
| 2020-09-30 | $72.91M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $64.94M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $72.33M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $74.49M 10-K · filed 2021-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |